-
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based StudiesMK Georgakis, JA de Lemos, C Ayers et al. -
From Focal Lipid Storage to Systemic InflammationP Libby, GK Hansson.
-
Negative Risk Markers for Cardiovascular Events in the ElderlyMB Mortensen, V Fuster, P Muntendam et al.
-
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyPerkovic V, Jardine MJ, CREDENCE Trial Investigators.
-
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art ReviewL Cho, M Davis, and for the ACC CVD Womens Committee Members.
-
Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesWanner C, Inzucchi SE, EMPA-REG OUTCOME Investigators.
-
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular eventsHD White, RAH Stewart et al on behalf of the STABILITY Investigators
-
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical TrialJS Hochman, HR Reynolds, S Bangalore et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
